497 related articles for article (PubMed ID: 33275888)
1. The Oncogenic Helicase ALC1 Regulates PARP Inhibitor Potency by Trapping PARP2 at DNA Breaks.
Blessing C; Mandemaker IK; Gonzalez-Leal C; Preisser J; Schomburg A; Ladurner AG
Mol Cell; 2020 Dec; 80(5):862-875.e6. PubMed ID: 33275888
[TBL] [Abstract][Full Text] [Related]
2. ALC1/CHD1L, a chromatin-remodeling enzyme, is required for efficient base excision repair.
Tsuda M; Cho K; Ooka M; Shimizu N; Watanabe R; Yasui A; Nakazawa Y; Ogi T; Harada H; Agama K; Nakamura J; Asada R; Fujiike H; Sakuma T; Yamamoto T; Murai J; Hiraoka M; Koike K; Pommier Y; Takeda S; Hirota K
PLoS One; 2017; 12(11):e0188320. PubMed ID: 29149203
[TBL] [Abstract][Full Text] [Related]
3. Structure and dynamics of the chromatin remodeler ALC1 bound to a PARylated nucleosome.
Bacic L; Gaullier G; Sabantsev A; Lehmann LC; Brackmann K; Dimakou D; Halic M; Hewitt G; Boulton SJ; Deindl S
Elife; 2021 Sep; 10():. PubMed ID: 34486521
[TBL] [Abstract][Full Text] [Related]
4. The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment.
Juhász S; Smith R; Schauer T; Spekhardt D; Mamar H; Zentout S; Chapuis C; Huet S; Timinszky G
Sci Adv; 2020 Dec; 6(51):. PubMed ID: 33355125
[TBL] [Abstract][Full Text] [Related]
5. A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene.
Singh HR; Nardozza AP; Möller IR; Knobloch G; Kistemaker HAV; Hassler M; Harrer N; Blessing C; Eustermann S; Kotthoff C; Huet S; Mueller-Planitz F; Filippov DV; Timinszky G; Rand KD; Ladurner AG
Mol Cell; 2017 Dec; 68(5):860-871.e7. PubMed ID: 29220653
[TBL] [Abstract][Full Text] [Related]
6. Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD.
Hewitt G; Borel V; Segura-Bayona S; Takaki T; Ruis P; Bellelli R; Lehmann LC; Sommerova L; Vancevska A; Tomas-Loba A; Zhu K; Cooper C; Fugger K; Patel H; Goldstone R; Schneider-Luftman D; Herbert E; Stamp G; Brough R; Pettitt S; Lord CJ; West SC; Ahel I; Ahel D; Chapman JR; Deindl S; Boulton SJ
Mol Cell; 2021 Feb; 81(4):767-783.e11. PubMed ID: 33333017
[TBL] [Abstract][Full Text] [Related]
7. Tripartite Motif-containing 33 (TRIM33) protein functions in the poly(ADP-ribose) polymerase (PARP)-dependent DNA damage response through interaction with Amplified in Liver Cancer 1 (ALC1) protein.
Kulkarni A; Oza J; Yao M; Sohail H; Ginjala V; Tomas-Loba A; Horejsi Z; Tan AR; Boulton SJ; Ganesan S
J Biol Chem; 2013 Nov; 288(45):32357-32369. PubMed ID: 23926104
[TBL] [Abstract][Full Text] [Related]
8. Chromatin remodeler ALC1 prevents replication-fork collapse by slowing fork progression.
Ooka M; Abe T; Cho K; Koike K; Takeda S; Hirota K
PLoS One; 2018; 13(2):e0192421. PubMed ID: 29408941
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP‑ribose) polymerase 1/2 inhibitors decrease the ubiquitination of ALC1 mediated by CHFR in breast cancer.
Wang Y; Wang Y; Wang N; You L; Long F; Shao C; Wang Y; Wu J
Oncol Rep; 2019 Oct; 42(4):1467-1474. PubMed ID: 31322269
[TBL] [Abstract][Full Text] [Related]
10. Common and unique genetic interactions of the poly(ADP-ribose) polymerases PARP1 and PARP2 with DNA double-strand break repair pathways.
Ghosh R; Roy S; Kamyab J; Danzter F; Franco S
DNA Repair (Amst); 2016 Sep; 45():56-62. PubMed ID: 27373144
[TBL] [Abstract][Full Text] [Related]
11. Activation of the SNF2 family ATPase ALC1 by poly(ADP-ribose) in a stable ALC1·PARP1·nucleosome intermediate.
Gottschalk AJ; Trivedi RD; Conaway JW; Conaway RC
J Biol Chem; 2012 Dec; 287(52):43527-32. PubMed ID: 23132853
[TBL] [Abstract][Full Text] [Related]
12. ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells.
Verma P; Zhou Y; Cao Z; Deraska PV; Deb M; Arai E; Li W; Shao Y; Puentes L; Li Y; Patankar S; Mach RH; Faryabi RB; Shi J; Greenberg RA
Nat Cell Biol; 2021 Feb; 23(2):160-171. PubMed ID: 33462394
[TBL] [Abstract][Full Text] [Related]
13. A Single-Molecule Atomic Force Microscopy Study of PARP1 and PARP2 Recognition of Base Excision Repair DNA Intermediates.
Sukhanova MV; Hamon L; Kutuzov MM; Joshi V; Abrakhi S; Dobra I; Curmi PA; Pastre D; Lavrik OI
J Mol Biol; 2019 Jul; 431(15):2655-2673. PubMed ID: 31129062
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1.
Ahel D; Horejsí Z; Wiechens N; Polo SE; Garcia-Wilson E; Ahel I; Flynn H; Skehel M; West SC; Jackson SP; Owen-Hughes T; Boulton SJ
Science; 2009 Sep; 325(5945):1240-3. PubMed ID: 19661379
[TBL] [Abstract][Full Text] [Related]
15. Revisiting PARP2 and PARP1 trapping through quantitative live-cell imaging.
Zhang H; Lin X; Zha S
Biochem Soc Trans; 2022 Aug; 50(4):1169-1177. PubMed ID: 35959996
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1.
Lehmann LC; Hewitt G; Aibara S; Leitner A; Marklund E; Maslen SL; Maturi V; Chen Y; van der Spoel D; Skehel JM; Moustakas A; Boulton SJ; Deindl S
Mol Cell; 2017 Dec; 68(5):847-859.e7. PubMed ID: 29220652
[TBL] [Abstract][Full Text] [Related]
17. PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib.
Ding X; Zhu Z; Lapek J; McMillan EA; Zhang A; Chung CY; Dubbury S; Lapira J; Firdaus S; Kang X; Gao J; Oyer J; Chionis J; Rollins RA; Li L; Niessen S; Bagrodia S; Zhang L; VanArsdale T
Sci Rep; 2022 Jul; 12(1):12501. PubMed ID: 35864202
[TBL] [Abstract][Full Text] [Related]
18. Multiple roles for PARP1 in ALC1-dependent nucleosome remodeling.
Ooi SK; Sato S; Tomomori-Sato C; Zhang Y; Wen Z; Banks CAS; Washburn MP; Unruh JR; Florens L; Conaway RC; Conaway JW
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34465625
[TBL] [Abstract][Full Text] [Related]
19. Serine-linked PARP1 auto-modification controls PARP inhibitor response.
Prokhorova E; Zobel F; Smith R; Zentout S; Gibbs-Seymour I; Schützenhofer K; Peters A; Groslambert J; Zorzini V; Agnew T; Brognard J; Nielsen ML; Ahel D; Huet S; Suskiewicz MJ; Ahel I
Nat Commun; 2021 Jul; 12(1):4055. PubMed ID: 34210965
[TBL] [Abstract][Full Text] [Related]
20. PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation.
Ronson GE; Piberger AL; Higgs MR; Olsen AL; Stewart GS; McHugh PJ; Petermann E; Lakin ND
Nat Commun; 2018 Feb; 9(1):746. PubMed ID: 29467415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
